Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Discover Online Value Through Advanced Intelligence Functionality

There are more than three billion social media users around the world. A company can only truly reach its full potential if it understands the depth of its online presence to connect with this audience; one Canadian artificial intelligence and machine learning Company ...
Stockhouse Editorial | February 5, 2020 |

Givex Information Technology: A global fintech platform empowering merchants

Givex Information Technology is a cloud-based, omnichannel technology platform that integrates products, such as gift cards, loyalty programs, and point-of-sale systems, to enterprise-level retail and hospitality merchants. Today I am joined by the company&CloseCurly...
Daniella Atkinson | October 17, 2022 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

Feb 28th 2020, Silver Chartbook – The weakest link

The weakest link The weakest link is you . That is not always easy to admit, but it is factual, that the main cause for large draw downs is human error. The list of errors in market participation is long. For example running stops or sitting frozen behind the monitor ...
Korbinian Koller | February 28, 2020 |

Mar 27th 2020, Silver Chartbook – Brace yourself

Brace yourself Right now you might find yourself in this first moment of catching a breath. You might have started getting used to a work from home. In addition, you might be feeling more prepared having stacked up on essentials. Maybe you even got used to this new wo...
Korbinian Koller | March 27, 2020 |

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...
Research | 10 days ago |

Commercialization Accelerates for POET Technologies’ Platform Technology

At POET Technologies, we have been a company of “-ization”. We had a goal for the “legitimization” of photonics in the semiconductor industry and built a hybrid-integration solution to deliver on the “optimization&CloseCurlyDoub...
Research | March 22, 2023 |

dynaCERT Inc. Set for Meteoric-Like Rise as an ESG Powerhouse

dynaCERT Inc. (TSX: DYA) (OTCQB: DYFSF) (Frankfurt: DMI) recently graduated to trading on the Canadian TSX Big Board. As a condition, prior to listing transition, the TSX exchange required dynaCERT do one capital raise based on a brokered deal (despite the fact the Company ...
Fredrick William | October 2, 2020 |

Top 5 Smart Contract Technology Platforms in 2019

Cryptocurrency is still the hot trend. The industry enjoyed a great boom in 2017 — then, Bitcoin skyrocketed, and so did almost all altcoins. ICOs also gained immense popularity, collecting more than $7 billion in investments . The trend was expected to continue in 2018, but ...
Julia Beyers | September 13, 2019 |

Kyorin's $175M Partnership Offers Good Life for aTyr Pharma in Japan

aTyr Pharma's shares traded 45% higher today after the firm reported that it had entered into a collaboration agreement with Kyorin Pharmaceutical for development and commercialization of its ATYR1923 drug in Japan. This morning, biotherapeutics company aTyr Pharma I...
Streetwise Reports | January 7, 2020 |
1 2 3